Dr Elizabeth Helen Kemp

All publications

Books

• (2022) Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Springer Nature Singapore.
• (2022) Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Springer Nature Singapore.
• (2022) Probiotics in the Prevention and Management of Human Diseases. Elsevier.

Journal articles

• Humbert L, Proust-Lemoine E, Dubucquoi S, Kemp EH, Saugier-Veber P, Fabien N, Raymond-Top I, Cardot-Bauters C, Carel J-C, Cartigny M , Chabre O et al (2024) Lessons from prospective longitudinal follow-up of a French APECED cohort. The Journal of Clinical Endocrinology & Metabolism. View this article in WRRO
• Dwivedi MK, Sankaranarayanan A, Helen Kemp E & Shoenfeld Y (2023) Preface. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases: Volume II: Kidney, Central Nervous System, Eye, Blood, Blood Vessels and Bowel, 2, vii.
• Dwivedi M, Tiwari S, Kemp EH & Begum R (2022) Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. Heliyon, 8(8).
• Mannstadt M, Cianferotti L, Gafni RI, Giusti F, Kemp EH, Koch CA, Roszko KL, Yao L, Guyatt GH, Thakker RV , Xia W et al (2022) Hypoparathyroidism : genetics and diagnosis. Journal of Bone and Mineral Research.
• Faraj S, Kemp EH & Gawkrodger DJ (2022) Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.. Clinical and Experimental Immunology. View this article in WRRO
• Dwivedi MK, Amaresan N, Sankaranarayanan A & Kemp EH (2022) Preface, xix-xix.
• Dwivedi MK, Amaresan N, Kemp EH & Shoenfeld Y (2022) Preface. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases: Volume I: Liver, Skin, Thyroid, Rheumatic and Myopathic Diseases, xi.
• Willemsen M, Post NF, van Uden NOP, Narayan VS, Chielie S, Kemp EH, Bekkenk MW & Luiten RM (2021) Immunophenotypic analysis reveals differences in circulating immune cells in the peripheral blood of patients with segmental and nonsegmental vitiligo. Journal of Investigative Dermatology.
• Eltumi H, Whatmore J, Kemp EH & Newell-Price J (2021) Antisense Oligonucleotides as a Novel Therapy for Cushing’s Disease. Journal of the Endocrine Society, 5(Suppl 1), a532-a533.
• Faraj S, Kemp EH & GAWKRODGER D (2021) Patho-immunological mechanisms of vitiligo: an integration of the immunogenetic milieu, with innate and adaptive immunities, as triggered by environmental stress factors.
• Sawicka B, Borysewicz-Sańczyk H, Michalak J, Wójtowicz J, Dobreńko E, Konstantynowicz J, Kemp EH, Thakker R, Allgrove J, Hanna F & Bossowski A (2020) Case report: A 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus. Journal of Pediatric Endocrinology and Metabolism. View this article in WRRO
• Bohm M, Kemp E, Metze D, Muresan AM, Neufeld M, Luiten RM & Ruck T (2020) Alemtuzumab-induced halo nevus-like hypopigmentation – New insights into secondary skin autoimmunity in response to an immune cell-depleting antibody. Journal of the European Academy of Dermatology and Venereology. View this article in WRRO
• Dadu R, Rodgers T, Trinh V, Kemp E, Cubb T, Patel S, Simon J, Burton E & Tawbi H (2020) Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up. Journal for ImmunoTherapy of Cancer, 8(1). View this article in WRRO
• Elder C, Vilela R, Johnson T, Taylor R, Kemp E, Keevil B, Cross A, Ross R & Wright N (2020) Pharmacodynamic studies of nasal tetracosactide with salivary glucocorticoids for a non-invasive Short Synacthen Test. Journal of Clinical Endocrinology and Metabolism. View this article in WRRO
• Semeraro A, Kemp EH, Pardi E, Di Certo A, Marcocci C & Cetani F (2020) Late-onset postsurgical hypoparathyroidism following parathyroidectomy for recurrent primary hyperparathyroidism: a case report and literature review. Endocrine, 69(2), 402-409. View this article in WRRO
• Miñambres I, Corcoy R, Weetman AP & Kemp EH (2020) Autoimmune Hypercalcemia Due to Autoantibodies Against the Calcium-sensing Receptor. The Journal of Clinical Endocrinology & Metabolism, 105(7), 2229-2236. View this article in WRRO
• Lupi I, Brancatella A, Cetani F, Latrofa F, Kemp EH & Marcocci C (2020) Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism, 105(5), 1581-1588. View this article in WRRO
• Humbert L, Dubucquoi S, Kemp E, Saugier-Veber P, Fabien N, Isabelle RT, Cardot-Bauters C, Maciejewski Cartigny M, Delemer B, Docao C , Carel J-C et al (2019) SUN-040 Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Syndrome: Prospective Screening of Asplenism and Pneumonitis in a Cohort of 25 Patients. Journal of the Endocrine Society, 3(Supplement_1).
• Piranavan P, Li Y, Brown E, Kemp EH & Trivedi N (2019) Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies. The Journal of Clinical Endocrinology & Metabolism, 104(2), 550-556. View this article in WRRO
• Chamberlin M, Kemp EH, Weetman AP, Khadka B & Brown EM (2019) Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor. Clinical Endocrinology, 90(1), 214-221. View this article in WRRO
• Habibullah M, Porter JA, Kluger N, Ranki A, Krohn KJE, Brandi ML, Brown EM, Weetman AP & Kemp EH (2018) Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity. The Journal of Immunology, 201(11), 3175-3183. View this article in WRRO
• Sandhu S, Desai A, Batra M, Girdhar R, Chatterjee K, Kemp EH, Makdissi A & Chaudhuri A (2018) Severe Symptomatic Hypocalcemia from HIV Related Hypoparathyroidism. Case Reports in Endocrinology, 2018, 1-4. View this article in WRRO
• Cross AS, Helen Kemp E, White A, Walker L, Meredith S, Sachdev P, Krone NP, Ross RJ, Wright NP & Elder CJ (2018) International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen. Clinical Endocrinology, 88(5), 744-751. View this article in WRRO
• Teulings H-E, Tjin EPM, Willemsen KJ, van der Kleij S, Meulen ST, Kemp EH, Krebbers G, van Noesel CJM, Franken CLMC, Drijfhout JW , Melief CJM et al (2018) Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial. OncoImmunology, 7(4), e1419113-e1419113. View this article in WRRO
• Kemp EH, Kahaly GJ, Porter JA, Frommer L & Weetman AP (2018) Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4. Clinical Endocrinology, 88(1), 139-145. View this article in WRRO
• Dwivedi M, Ansarullah , Radichev I & Kemp EH (2017) Alteration of Immune-Mechanisms by Human Microbiota and Development and Prevention of Human Diseases. Journal of Immunology Research, 2017, 1-2. View this article in WRRO
• Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA, Siebert J, Hartmann A , Lienert A et al (2016) Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nature Genetics, 48(11), 1418-1424. View this article in WRRO
• Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB , Myhre AG et al (2016) Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. The Journal of Clinical Endocrinology & Metabolism, 101(8), 3045-3053. View this article in WRRO
• Dwivedi M, Kumar P, Laddha NC & Kemp EH (2016) Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity. Autoimmunity Reviews, 15(4), 379-392. View this article in WRRO
• Helen Kemp E, Ajjan RA, Metcalfe RA, Watson PF & Weetman AP (2015) IL-14 and IL-16 are expressed in the thyroid of patients with either Graves’ disease or Hashimoto's thyroiditis. Clinical Endocrinology, 83(5), 726-732. View this article in WRRO
• Pradhan V, Kemp EH, Nadkar M, Rajadhyaksha A, Lokhandwala K, Patwardhan M, Weetman AP, Nadkarni A & Ghosh K (2015) Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to systemic lupus erythematosus in an Indian population. Scandinavian Journal of Rheumatology, 44(5), 425-427. View this article in WRRO
• Dubucquoi S, Proust-Lemoine E, Kemp EH, Ryndak A, Lefèvre-Dutoit V, Bellart M, Saugier-Véber P, Duban-Deweer S, Wémeau J-L, Prin L & Lefranc D (2015) Serological proteome analysis reveals new specific biases in the IgM and IgG autoantibody repertoires in autoimmune polyendocrine syndrome type 1. Autoimmunity, 48(8), 532-541. View this article in WRRO
• Mezgueldi E, Bertholet‐Thomas A, Milazzo S, Morris M, Bacchetta J, Fabien N, Cochat P, Weetman AP, Kemp EH & Belot A (2015) Early‐onset hypoparathyroidism and chronic keratitis revealing APECED. Clinical Case Reports, 3(10), 809-813. View this article in WRRO
• Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP , Fleishman SJ et al (2015) Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases. Immunity, 42(6), 1185-1196. View this article in WRRO
• Mathieu A-L, Verronese E, Rice GI, Fouyssac F, Bertrand Y, Picard C, Chansel M, Walter JE, Notarangelo LD, Butte MJ , Nadeau KC et al (2015) PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator–dependent autoimmunity. Journal of Allergy and Clinical Immunology, 135(6), 1578-1588.e5. View this article in WRRO
• Dwivedi M, Helen Kemp E, Laddha NC, Mansuri MS, Weetman AP & Begum R (2015) Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics. Autoimmunity Reviews, 14(1), 49-56. View this article in WRRO
• Bellacchio E, Palma A, Corrente S, Di Girolamo F, Helen Kemp E, Di Matteo G, Comelli L, Carsetti R, Cascioli S, Cancrini C & Fierabracci A (2014) The possible implication of the S250C variant of the autoimmune regulator protein in a patient with autoimmunity and immunodeficiency: in silico analysis suggests a molecular pathogenic mechanism for the variant. Gene, 549(2), 286-294.
• Brix TH, Hegedüs L, Weetman AP & Kemp HE (2014) Pendrin and NIS antibodies are absent in healthy individuals and are rare in autoimmune thyroid disease: evidence from a Danish twin study. Clinical Endocrinology, 81(3), 440-444.
• Kemp EH, Habibullah M, Kluger N, Ranki A, Sandhu HK, Krohn KJE & Weetman AP (2014) Prevalence and Clinical Associations of Calcium-Sensing Receptor and NALP5 Autoantibodies in Finnish APECED Patients. The Journal of Clinical Endocrinology & Metabolism, 99(3), 1064-1071.
• Teulings H-E, Willemsen KJ, Glykofridis I, Krebbers G, Komen L, Kroon MW, Kemp EH, Wolkerstorfer A, van der Veen JPW, Luiten RM & Tjin EPM (2014) The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo. Pigment Cell & Melanoma Research, 27(6), 1086-1096.
• Godlewska M, Góra M, Buckle AM, Porebski BT, Kemp EH, Sutton BJ, Czarnocka B & Banga JP (2014) A Redundant Role of Human Thyroid Peroxidase Propeptide for Cellular, Enzymatic, and Immunological Activity. Thyroid, 24(2), 371-382.
• Patwardhan M, Pradhan V, Taylor LH, Thakkar V, Kharkar V, Khopkar U, Ghosh K, Gawkrodger DJ, Teare MD, Weetman AP & Kemp EH (2013) The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis. British Journal of Dermatology, 168(6), 1195-1204.
• Pradhan V, Patwardhan M, Thakkar V, Kharkar V, Khopkar U, Ghosh K, Weetman AP, Gawkrodger DJ & Kemp EH (2013) Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries. Journal of the European Academy of Dermatology and Venereology, 27(3), 279-286.
• Teulings HE, Tjin EPM, Willemsen KJ, Krebbers G, van Noesel CJ, Kemp EH, Nieuweboer-Krobotova L, van der Veen JPW & Luiten RM (2013) Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis. British Journal of Dermatology, 168(4), 733-738.
• Kemp EH, Sandhu HK, Watson PF & Weetman AP (2013) Low Frequency of Pendrin Autoantibodies Detected Using a Radioligand Binding Assay in Patients With Autoimmune Thyroid Disease. The Journal of Clinical Endocrinology & Metabolism, 98(2), E309-E313.
• Kuo E, Kemp EH, Sandhu HK, Brown EM, Weetman AP & Huang C-L (2013) Acquired Hypocalciuric Hypercalcemia in a Patient With CKD. American Journal of Kidney Diseases, 62(6), 1151-1154.
• Melcescu E, Kemp EH, Majithia V, Vijayakumar V, Uwaifo GI & Koch CA (2013) Graves' Disease, Hypoparathyroidism, Systemic Lupus Erythematosus, Alopecia, and Angioedema: Autoimmune Polyglandular Syndrome Variant or Coincidence?. International Journal of Immunopathology and Pharmacology, 26(1), 217-222.
• Kroon MW, Kemp EH, Wind BS, Krebbers G, Bos JD, Gawkrodger DJ, Wolkerstorfer A, van der Veen JPW & Luiten RM (2013) Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. Journal of the European Academy of Dermatology and Venereology, 27(9), 1172-1175.
• Rahoma SFE, Sandhu HK, McDonagh AJG, Gawkrodger DJ, Weetman AP & Kemp EH (2012) Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients. British Journal of Dermatology, 167(1), 17-28.
• Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC , Luiten RM et al (2012) Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nature Genetics, 44(6), 676-680. View this article in WRRO
• Kemp EH, Sandhu HK, Weetman AP & McDonagh AJ (2011) Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata. British Journal of Dermatology, 165(6), 1236-1243.
• Harris HE, Kemp EH, Brown EM, Weetman AP & Swaminathan K (2011) First report of anti-calcium-sensing receptor antibodies in a patient with Sjogren's syndrome and primary hypoparathyroidism. Rheumatology, 50(6), 1173-1175.
• Pallais JC, Kemp EH, Bergwitz C, Kantham L, Slovik DM, Weetman AP & Brown EM (2011) Autoimmune Hypocalciuric Hypercalcemia Unresponsive to Glucocorticoid Therapy in a Patient with Blocking Autoantibodies against the Calcium-Sensing Receptor. The Journal of Clinical Endocrinology & Metabolism, 96(3), 672-680.
• Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Helen Kemp E, Gawkrodger DJ, Weetman AP, Picardo M , Leone G et al (2011) Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLP. Journal of Investigative Dermatology, 131(2), 371-381. View this article in WRRO
• Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT , Kemp EH et al (2011) Genome-Wide Analysis Identifies a Quantitative Trait Locus in the MHC Class II Region Associated with Generalized Vitiligo Age of Onset. Journal of Investigative Dermatology, 131(6), 1308-1312.
• Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ & Weetman AP (2011) Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Experimental Dermatology, 20(1), 35-40.
• Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, Holland PJ, Bennett DC, Wallace MR, McCormack WT , Kemp EH et al (2010) Common variants in FOXP1 are associated with generalized vitiligo. Nature Genetics, 42(7), 576-578. View this article in WRRO
• Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJD, Hutton SM, Amadi-Myers A , Bennett DC et al (2010) Variant ofTYRand Autoimmunity Susceptibility Loci in Generalized Vitiligo. New England Journal of Medicine, 362(18), 1686-1697. View this article in WRRO
• Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP & Kemp EH (2010) Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.. Journal of Investigative Dermatology, 130(1), 230-240.
• Kemp EH, Gavalas NG, Akhtar S, Krohn KJE, Pallais JC, Brown EM, Watson PF & Weetman AP (2010) Mapping of human autoantibody binding sites on the calcium-sensing receptor. Journal of Bone and Mineral Research, 25(1), 132-140. View this article in WRRO
• Kemp EH, Gavalas NG, Krohn KJE, Brown EM, Watson PF & Weetman AP (2009) Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1. The Journal of Clinical Endocrinology & Metabolism, 94(12), 4749-4756.
• Kemp EH & Weetman AP (2009) Melanin-concentrating hormone and melanin-concentrating hormone receptors in mammalian skin physiopathology.. Peptides, 30(11), 2071-2075.
• Gavalas NG, Gottumukkala RV, Gawkrodger DJ, Watson PF, Weetman AP & Kemp EH (2009) Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies.. Experimental Dermatology, 18(5), 454-463.
• Bradley V, Kemp EH, Dickinson C, Key T, Gibbs P & Clatworthy MR (2009) Vitiligo following a combined liver-kidney transplant.. Nephrology Dialysis and Transplantation, 24(2), 686-688.
• Skinningsrud B, Husebye ES, Gervin K, Lovas K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE (2008) Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. European Journal of Human Genetics, 16(8), 977-982.
• Ralf Paus L, Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, Giachino C, Liu JB, Luiten RM , Lambe T et al (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?. Experimental Dermatology, 17(2), 139-160.
• Ralf Paus L, Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, Giachino C, Liu JB, Luiten RM , Lambe T et al (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?. Experimental Dermatology, 17(2), 139-140.
• Kemp EH (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Commentary 1. Experimental Dermatology, 17(2), 150-151.
• Helen Kemp E (2008) Commentary 1. Experimental Dermatology, 17(2), 150-151.
• Kemp EH, Gavalas NG & Weetman AP (2007) The aetiology and pathogenesis of vitiligo: The role of immunological factors. Current Trends in Immunology, 8, 87-101.
• Rezaei N, Gavalas NG, Weetman AP & Kemp EH (2007) Autoimmunity as an aetiological factor in vitiligo.. Journal of European Academy of Dermatology and Venereology, 21(7), 865-876.
• Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF & Weetman AP (2007) The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.. Journal of Clinical Endocrinology and Metabolism, 92(6), 2107-2114.
• Cantón I, Sarwar U, Kemp EH, Ryan AJ, MacNeil S & Haycock JW (2007) Real-time detection of stress in 3D tissue-engineered constructs using NF-kappaB activation in transiently transfected human dermal fibroblast cells.. Tissue Engineering, 13(5), 1013-1024.
• Kemp EH, Gavalas NG, Gawkrodger DJ & Weetman AP (2007) Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.. Autoimmun Reviews, 6(3), 138-142.
• Dubska M, Banga JP, Plochocka D, Hoser G, Kemp EH, Sutton BJ, Gardas A & Gora M (2006) Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies.. Endocrinology, 147(12), 5995-6003.
• Gottumukkala RV, Gavalas NG, Akhtar S, Metcalfe RA, Gawkrodger DJ, Haycock JW, Watson PF, Weetman AP & Kemp EH (2006) Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.. Laboratory Investigation, 86(8), 781-789.
• Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, Weetman AP & Kemp EH (2006) Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.. Biochemical and Biophysical Research Communications, 345(4), 1586-1591.
• Kemp EH, McDonagh AJ, Wengraf DA, Messenger AG, Gawkrodger DJ, Cork MJ & Tazi-Ahnini R (2006) The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata.. Human Immunology, 67(7), 535-539.
• Cantón I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP & Kemp EH (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.. Genes and Immunity, 6(7), 584-587.
• Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP & Kemp EH (2005) An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population.. Arch Dermatol Res, 297(2), 94-98.
• Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA & Undlien DE (2005) CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Research, 18(1), 55-58.
• Kemp EH (2004) Autoantibodies as diagnostic and predictive markers of vitiligo.. Autoimmunity, 37(4), 287-290.
• Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES & Undlien DE (2004) Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease.. J Clin Endocrinol Metab, 89(7), 3474-3476.
• Zhu N, Lalla R, Eves P, Brown TLH, King A, Kemp EH, Haycock JW & MacNeil S (2004) Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone.. Br J Cancer, 90(7), 1457-1463. View this article in WRRO
• Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S & Haycock JW (2004) alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.. J Invest Dermatol, 122(4), 1010-1019.
• Eves PC, Haycock JW, Layton C, Wagner M, Kemp EH, Szabo M, Morandini R, Ghanem G, Garcia-Barrón J-C & Jiménez-Cervantes C (2003) Anti-inflammatory and anti-invasive effects of alpha-melanocyte stimulating hormone in human melanoma cells. Br J Cancer, 89(10), 2004-2015. View this article in WRRO
• Gottumukkala RVSRK, Waterman EA, Herd LM, Gawkrodger DJ, Watson PF, Weetman AP & Kemp EH (2003) Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.. J Invest Dermatol, 121(4), 765-770.
• Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF & Weetman AP (2003) Detection and localization of chemokine gene expression in autoimmune thyroid disease.. Clin Endocrinol (Oxf), 59(2), 207-213.
• Kemp EH, Metcalfe RA, Watson PF & Weetman AP (2003) HLA-G does not have a pathophysiological role in Graves' disease.. J Clin Pathol, 56(6), 475-477.
• Kemp EH, Herd LM, Waterman EA, Wilson AG, Weetman AP & Watson PP (2002) Immunoscreening of phage-displayed cDNA-encoded polypeptides identifies B cell targets in autoimmune disease.. Biochem Biophys Res Commun, 298(1), 169-177.
• Waterman EA, Kemp EH, Gawkrodger DJ, Watson PF & Weetman AP (2002) Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.. Clin Exp Immunol, 129(3), 527-532.
• Kemp EH, Waterman EA, Hawes BE, O'Neill K, Gottumukkala RVSRK, Gawkrodger DJ, Weetman AP & Watson PF (2002) The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.. J Clin Invest, 109(7), 923-930.
• Moustafa M, Szabo M, Ghanem GE, Morandini R, Kemp EH, MacNeil S & Haycock JW (2002) Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.. J Invest Dermatol, 119(6), 1244-1253.
• Kemp EH, Waterman EA & Weetman AP (2001) Autoimmune aspects of vitiligo.. Autoimmunity, 34(1), 65-77.
• Kemp EH, Waterman EA & Weetman AP (2001) Immunological pathomechanisms in vitiligo.. Expert Rev Mol Med, 3(20), 1-22.
• Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF & Weetman AP (2001) Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.. Clin Exp Immunol, 124(3), 509-515.
• Kemp EH, Waterman EA, Ajjan RA, Smith KA, Watson PF, Ludgate ME & Weetman AP (2001) Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.. Clin Exp Immunol, 124(3), 377-385.
• Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye E, Gustafsson J, Betterle C , Kämpe O et al (2001) The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.. J Biol Chem, 276(38), 35390-35395.
• Czarnocka B, Pastuszko D, Janota-Bzowski M, Weetman AP, Watson PF, Kemp EH, McIntosh RS, Asghar MS, Jarzab B, Gubala E , Wloch J et al (2001) Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?. Br J Cancer, 85(6), 875-880. View this article in WRRO
• Hudson KD, Corfe BM, Kemp EH, Feavers IM, Coote PJ & Moir A (2001) Localization of GerAA and GerAC germination proteins in the Bacillus subtilis spore.. J Bacteriol, 183(14), 4317-4322.
• Kemp EH, Ridgway JN, Smith KA, Watson PF & Weetman AP (2000) Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.. Clin Endocrinol (Oxf), 53(3), 291-299.
• Ajjan RA, Kemp EH, Waterman EA, Watson PF, Endo T, Onaya T & Weetman AP (2000) Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.. J Clin Endocrinol Metab, 85(5), 2020-2027.
• Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF , Kemp EH et al (2000) Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease.. J Clin Endocrinol Metab, 85(2), 688-691.
• Kemp EH, Ajjan RA, Waterman EA, Gawkrodger DJ, Cork MJ, Watson PF & Weetman AP (1999) Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.. Br J Dermatol, 140(1), 73-78.
• Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF & Weetman AP (1999) Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.. J Invest Dermatol, 113(2), 267-271.
• Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF & Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.. Br J Dermatol, 139(5), 798-805.
• Kemp EH, Gawkrodger DJ, Watson PF & Weetman AP (1998) Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).. Clin Exp Immunol, 114(3), 333-338.
• Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF & Weetman AP (1998) A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.. Clin Endocrinol (Oxf), 49(5), 609-613.
• Kemp EH, Gawkrodger DJ, Watson PF & Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).. Clin Exp Immunol, 109(3), 495-500.
• Czarnocka B, Janota-Bzowski M, McIntosh RS, Asghar MS, Watson PF, Kemp EH, Carayon P & Weetman AP (1997) Immunoglobulin G kappa antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope-mapping analysis.. J Clin Endocrinol Metab, 82(8), 2639-2644.
• McIntosh RS, Asghar MS, Kemp EH, Watson PF, Gardas A, Banga JP & Weetman AP (1997) Analysis of immunoglobulin G kappa antithyroid peroxidase antibodies from different tissues in Hashimoto's thyroiditis.. J Clin Endocrinol Metab, 82(11), 3818-3825.
• Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF & Weetman AP (1997) Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.. J Invest Dermatol, 109(1), 69-73.
• McIntosh RS, Asghar MS, Watson PF, Kemp EH & Weetman AP (1996) Cloning and analysis of IgG kappa and IgG lambda anti-thyroglobulin autoantibodies from a patient with Hashimoto's thyroiditis: evidence for in vivo antigen-driven repertoire selection.. J Immunol, 157(2), 927-935.
• Kemp EH, Sammons RL, Moir A, Sun D & Setlow P (1991) Analysis of transcriptional control of the gerD spore germination gene of Bacillus subtilis 168.. J Bacteriol, 173(15), 4646-4652.
• Moir A, Yazdi MA & Kemp EH (1991) Spore germination genes of Bacillus subtilis 168.. Res Microbiol, 142(7-8), 847-850.
• Kemp EH, Minton NP & Mann NH (1987) Complete nucleotide sequence and deduced amino acid sequence of the M5 polypeptide gene of Escherichia coli K12. Nucleic Acids Res, 15, 3924-3924.
• Cantòn I, Cole DM, Kemp EH, Watson PF, Chunthapong J, Ryan AJ, MacNeil S & Haycock JW () Development of a 3D human in vitro skin co-culture model for detecting irritants in real-time. Biotechnology and Bioengineering, 106(5), 794-803.

Chapters

• Giri PS, Bharti A, Kemp EH & Dwivedi MK (2022) Microorganisms in Pathogenesis and Management of Vitiligo, Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases (pp. 189-223). Springer Nature Singapore
• Dwivedi MK, Amaresan N, Sankaranarayanan A & Kemp EH (2022) Preface, Probiotics in the Prevention and Management of Human Diseases (pp. xix). Elsevier
• Kemp EH & Weetman AP (2015) Autoimmune hypoparathyroidism In Brandi ML & Brown EM (Ed.), Hypoparathyroidism (pp. 177-188). Milan, Italy: Springer-Verlag Italia.
• Dwivedi M, Laddha NC, Weetman AP, Begum R & Kemp EH (2015) Vitiligo: A complex autoimmune skin depigmenting disease In Chatzidionysiou K (Ed.), Autoimmune Diseases - Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases (pp. 153-173). Rijeka, Croatia: InTech.
• Kemp EH, Emhemad S, Gawkrodger DJ & Weetman AP (2011) Autoimmunity in vitiligo In Mavragani C (Ed.), Autoimmune Disorders - Pathogenic Aspects (pp. 271-294). Rijeka, Croatia: InTech.
• Kemp EH, Weetman AP & Gawkrodger DJ (2010) Humoral immunity In Picardo M & Taïeb A (Ed.), Vitiligo (pp. 248-256). Heidelberg, Germany: Springer.
• Kemp EH, Waterman EA & Weetman AP (2004) Cytotoxic T lymphocyte antigen-4 in autoimmune thyroid disease and vitiligo In Pociot F (Ed.), CTLA-4 in Autoimmune Disease (pp. 45-54). Austin, Texas, USA: Eurekah.Com Inc.
• Weetman AP, Kemp EH, Ridgway JN & Watson PF (2001) Orbital autoantigens In Bahn RS (Ed.), Thyroid Eye Disease (pp. 1-20). Dordrecht, The Netherlands: Springer.

Conference proceedings papers

• Willemsen M, Post NF, van Uden NOP, Narayan VS, Chielie S, Kemp EH, Bekkenk MW & Luiten RM (2021) Immunophenotypic analysis reveals differences in circulating immune cells in peripheral blood of segmental and non-segmental vitiligo patients. EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 51 (pp 355-355)
• Moir A, Kemp EH, Robinson C & Corfe BM (1994) The genetic analysis of bacterial spore germination.. J Appl Bacteriol, Vol. 77(3) (pp 9S-16S). England

Reports

• Kemp EH (2015) Tumour necrosis factor-α antagonists as therapies for vitiligo View this article in WRRO
• Kemp EH (2015) The CC genotype of the ERCC 1 C118T single‐nucleotide polymorphism impacts positively on the efficacy of narrowband ultraviolet B therapy for vitiligo View this article in WRRO
• Kemp EH (2015) Programmed death 1 expressing regulatory T cells in vitiligo View this article in WRRO
• Kemp EH (2014) Antithyroid hormone autoantibodies in vitiligo
• Kemp EH (2007) Autologous cultured melanocytes in vitiligo treatment - Commentary
• Kemp EH (2007) Profiling autoantibody responses in vitiligo
• Kemp EH (2007) Commentary: Autologous cultured melanocytes in vitiligo treatment
• Kemp EH (2006) A receptor targeted by autoantibodies in vitiligo